Tina Flatau
Director/Miembro de la Junta en Sixfold Bioscience, Inc. .
Perfil
Tina Flatau is currently a Director at Sixfold Bioscience, Inc. She previously worked as the Managing Director at MedAnnex Ltd.
and as the Vice President-Alliances & Project Management at Prosensa Holding NV.
Cargos activos de Tina Flatau
Empresas | Cargo | Inicio |
---|---|---|
Sixfold Bioscience, Inc.
Sixfold Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sixfold Bioscience Ltd., Sixfold Bioscience, Inc. operates as a biotechnology company that develops next-generation in vivo delivery systems for RNA therapeutics. The company is based in Walnut, CA. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Tina Flatau.
Empresas | Cargo | Fin |
---|---|---|
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Director Ejecutivo | 01/03/2019 |
PROSENSA HOLDING NV | Corporate Officer/Principal | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Prosensa Holding NV
Prosensa Holding NV BiotechnologyHealth Technology Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands. | Health Technology |
MedAnnex Ltd.
MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
Sixfold Bioscience, Inc.
Sixfold Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sixfold Bioscience Ltd., Sixfold Bioscience, Inc. operates as a biotechnology company that develops next-generation in vivo delivery systems for RNA therapeutics. The company is based in Walnut, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Tina Flatau